YgEia3 Ltd

Founded in 2014 and based in London, UK, YgEia3 Ltd specializes in advanced scientific wellness assessments that evaluate physiological profiles to improve health outcomes. In October 2024, UBSWLS Equity acquired YgEia3 for GBP 260 million. As of 2024, the company is led by its CEO, Disa Sanstorn. YgEia3 specializes in advanced scientific wellness testing, focusing on the assessment of various physiological profiles to enhance overall health and wellness.

The firm’s core offerings include evaluations of vitamin and mineral sufficiency, neurotransmitter metabolism, oxidative stress markers, and mitochondrial energy production. The company aims to identify food sensitivities and chemical imbalances that can impact mood and sleep among individuals and organizations, including corporate clients and athletic teams. By leveraging laboratory results, YgEia3 provides tailored wellness programs that feature custom vitamin and mineral formulas, amino acid blends, and an online food reaction guide. YgEia3 serves a global client base, primarily targeting markets in North America, Europe, and Asia, catering to both individual consumers and organizational partners seeking to improve overall health outcomes.

YgEia3 generates revenue that engages in B2B transactions, primarily partnering with corporations, colleges, and professional sports teams, ensuring that their offerings meet the specific needs of these clients. Revenue streams consist of service contracts where clients subscribe to regular wellness assessments and consultations.